<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00794651</url>
  </required_header>
  <id_info>
    <org_study_id>AR_08_MK_01</org_study_id>
    <nct_id>NCT00794651</nct_id>
  </id_info>
  <brief_title>Osteoarthritis Bedside Testing Kit</brief_title>
  <official_title>Development of a Bedside Pain Assessment Kit for Evaluating Effectiveness of Drugs for Osteoarthritis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Analgesic Solutions</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Analgesic Solutions</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Develop and test a bedside testing kit for evaluating pain and symptoms of osteoarthritis
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Conduct a Focus group of subjects with painful osteoarthritis of the knee to evaluate
      potential kit for acceptability to subjects and investigators, and usability, clarity of
      instructions, appropriateness of the data capture, simplicity, subject and investigator
      burden, and overall impressions of the procedures.

      Conduct a reliability and usability study with subjects with painful osteoarthritis of the
      knee to determine Intra-rater reliability, Inter-rater reliability, Kit reliability.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>January 2009</start_date>
  <completion_date type="Anticipated">June 2009</completion_date>
  <primary_completion_date type="Anticipated">May 2009</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">25</enrollment>
  <condition>Osteoarthritis</condition>
  <arm_group>
    <arm_group_label>OA</arm_group_label>
    <description>moderate to severe osteoarthritis of the knee</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        moderate to severe osteoarthritis of the knee .
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subject is 50 years of age or older and has osteoarthritis of the knee.

          -  Subject is able to communicate meaningfully in English and comply with all study
             procedures.

          -  Subject is willing to voluntarily sign and date an informed consent form, approved by
             an Institutional Review Board (IRB)/Independent Ethics Committee (IEC), prior to the
             conduct of any study-specific procedures.

          -  Subject has experienced a minimum duration of pain of at least 6 months.

          -  For each of the last 15 days, pain level has remained at least a 3 on a Pain Intensity
             Numerical Rating (P-NRS) scale from 0 to 10; 0 means &quot;no pain&quot; and 10 means &quot;worst
             pain imaginable&quot;.

          -  Subject is ambulatory.

          -  Subject has a primary diagnosis of osteoarthritis of the knee by medical history.

          -  Subject must be willing to abstain from any pain medicine for 12 hours prior to the
             study.

        Exclusion Criteria:

          -  â€¢ Subject is pregnant and/or breast-feeding.

               -  Subject has a medical condition, other than OA, that is not well-controlled with
                  treatment; or the subject has any clinically significant condition that would, in
                  the opinion of the investigator, preclude study participation or interfere with
                  the assessment of pain and other symptoms of OA.

               -  Subject is not able to hold a stylus or pen.

               -  Subject is not able to read a computer screen.

               -  Subject has any chronic pain syndrome (e.g., fibromyalgia) that, in the
                  investigator's opinion, would interfere with the assessment of pain and/or other
                  symptoms of OA.

               -  In the judgment of the investigator, the subject has a psychiatric or
                  psychological disorder that would interfere with the completion of the study,
                  confound the study results or pose patient risk.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nathaniel Katz, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Analgesic Research</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Thomas A Eaton, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Analgesic Research</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Thomas A Eaton, PhD</last_name>
    <phone>781-444-9605</phone>
    <email>teaton@analgesicresearch.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Analgesic Research, LLC</name>
      <address>
        <city>Needham</city>
        <state>Massachusetts</state>
        <zip>02494</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Thomas A Eaton, PhD</last_name>
      <phone>781-444-9605</phone>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 19, 2008</study_first_submitted>
  <study_first_submitted_qc>November 19, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 20, 2008</study_first_posted>
  <last_update_submitted>November 19, 2008</last_update_submitted>
  <last_update_submitted_qc>November 19, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 20, 2008</last_update_posted>
  <responsible_party>
    <name_title>Nathaniel Katz, MD</name_title>
    <organization>Analgesic Research, LLC</organization>
  </responsible_party>
  <keyword>osteoarthritis</keyword>
  <keyword>testing kit</keyword>
  <keyword>knee</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

